3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
704
Neoplasms
622
Prostatic Neoplasms
323
Lung Neoplasms
316
Colorectal Neoplasms
285
Carcinoma, Non-Small-Cell Lung
260
Pancreatic Neoplasms
181
Carcinoma, Hepatocellular
172
Stomach Neoplasms
141
Multiple Myeloma
128
Ovarian Neoplasms
123
Melanoma
119
Colonic Neoplasms
114
Brain Neoplasms
111
Hematologic Neoplasms
107
Head and Neck Neoplasms
106
Urinary Bladder Neoplasms
104
Leukemia, Myeloid, Acute
102
Esophageal Neoplasms
101
Disease
100
Uterine Cervical Neoplasms
91
Liver Neoplasms
91
Neoplasm Metastasis
90
Lymphoma
86
Rectal Neoplasms
85
Precursor Cell Lymphoblastic Leukemia-Lymphoma
84
Endometrial Neoplasms
79
Carcinoma, Renal Cell
74
Leukemia
65
Recurrence
63
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Macular Edema
×
1 year
×
Clear all
NCT05605782
2025-06-26
ORION
Bristol-Myers Squibb
Active not recruiting
9,000 enrolled